TARDBP and supranuclear palsy, progressive, 1: Participants with clinical FTLD and CBD/PSP were more likely to have been assessed for TDP-43 (FTLD, 97%; CBD/PSP, 93%) compared to other presumptive etiologic diagnoses (80–85%).